← back to search

Mira Katan

University of Basel · CH
Area of research
Nutrition and Dietetics · Epidemiology
Research interest
Research interests include Fatty Acid Research and Health, Acute Ischemic Stroke Management, Diet and metabolism studies, and Cholesterol and Lipid Metabolism.
h-index
103
citations
51,835
works
681
NIH funding
primary concept
Medicine
email

Recent publications

Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
New England Journal of Medicine 2025cited by 190position: middledoi
Levodopa Added to Stroke Rehabilitation
JAMA 2025cited by 10position: middledoi
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
JAMA Network Open 2025cited by 4position: middledoi
Safety of endovascular therapy in ischemic stroke patients ⩾90 years: A cohort study from the EVA-TRISP collaboration
European Stroke Journal 2025cited by 1position: middledoi
Platelet inhibition strategies in rescue stenting after failed thrombectomy: a large retrospective multicenter registry
Therapeutic Advances in Neurological Disorders 2025cited by 1position: middledoi
Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis
European Stroke Journal 2024cited by 51position: middledoi
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
JAMA Neurology 2024cited by 30position: middledoi
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial
Circulation 2024cited by 24position: middledoi
Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: A World Stroke Organization (WSO) scientific statement
International Journal of Stroke 2024cited by 13position: middledoi
Prevalence and Distribution of Intracranial Vessel Occlusion on Angiography and Its Association with Functional Outcome in Patients with Atrial Fibrillation Presenting with Ischemic Stroke
Annals of Neurology 2024cited by 9position: middledoi
Insights into vessel perforations during thrombectomy: Characteristics of a severe complication and the effect of thrombolysis
European Stroke Journal 2024cited by 7position: middledoi
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
JAMA Neurology 2023cited by 117position: middledoi
Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation
Journal of Neurology Neurosurgery & Psychiatry 2022cited by 91position: middledoi
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study
European Heart Journal 2021cited by 91position: lastdoi
External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood Biomarkers
Stroke 2020cited by 39position: middledoi
Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage
Stroke 2017cited by 14position: firstdoi
Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke
Stroke 2016cited by 33position: firstdoi
Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
PLoS ONE 2014cited by 54position: firstdoi
Copeptin adds prognostic information after ischemic stroke
Neurology 2013cited by 92position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mitchell S.V. Elkind · Sage Colleges3 papers (2014–2017)Marcel Arnold · Norwegian Womens Public Health Association3 papers (2013–2024)Yeseon Park Moon · King Abdul Aziz University Hospital3 papers (2014–2017)Beat Müeller · Kantonsspital Aarau2 papers (2013–2016)Ashkan Shoamanesh · Queen Elizabeth II Health Sciences Centre2 papers (2024–2024)Joan Montaner · Biomedical Research Institute2 papers (2020–2021)Gian Marco De Marchis · University of St.Gallen2 papers (2013–2021)Leo H. Bonati · Spitäler Schaffhausen2 papers (2021–2024)David Seiffge · University of Bern2 papers (2024–2024)Carlo W. Cereda · Laboratory for Biomedical Neurosciences2 papers (2021–2024)Timo Kahles · University of Liverpool2 papers (2021–2024)Christian Foerch · University of Liverpool2 papers (2013–2021)Georg Kägi · Population Health Research Institute2 papers (2021–2024)Alejandro Bustamante · Select Engineering Services (United States)2 papers (2020–2021)Ralph L. Sacco · Lotus Clinical Research2 papers (2016–2017)Urs Fischer · Amsterdam Neuroscience2 papers (2021–2024)Myunghee Cho Paik · Shepherd University2 papers (2014–2016)Arnold von Eckardstein · University of Zurich2 papers (2017–2021)Philipp Schüetz · Kantonsspital Aarau1 papers (2013–2013)Lina Palaiodimou · McMaster University1 papers (2024–2024)